<?xml version="1.0" encoding="UTF-8"?>
<p id="p0350">The antiviral action of nitric oxide (NO) has been reported for the treatment of several DNA and RNA virus families 
 <xref rid="b0530" ref-type="bibr">[106]</xref>. Therefore, a novel approach to arrest SARS-CoV-2 life cycle could be targeting cysteines of TMPRSS2 through a covalent attachment of a nitrogenous group (â€“NO). As NO and NO donors are able to nitrosylate thiol group, inhaled NO in COVID-19 patients could potentially be an effective therapy 
 <xref rid="b0535" ref-type="bibr">[107]</xref>.
</p>
